Lymphedema, a chronic condition often stemming from cancer treatments, leads to tissue swelling. Early detection through surveillance programs and proper skincare can prevent complications like infections.

Norovirus, discovered in 1972, causes millions of gastroenteritis cases yearly. Learn prevention methods, symptoms, and updates on vaccine development.

A recent study’s results demonstrate that PuraCath Medical Inc.'s breakthrough UV-C device disinfects needleless connectors, potentially reducing CLABSI risks in hospital settings.

Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?

Staying Ahead with Company Updates and Product Innovations. Read the news from PerfectClean, the FDA, and the CDC.

Noah Wald-Dickler, MD, FACP, discusses the safety and efficacy of oral transition therapy, challenges in antimicrobial stewardship, and evidence-based alternatives presented at SHEA 2024.

Opinion: Kevin Kavanagh, MD, examines a summary of studies on how COVID-19 may damage the brain's frontal lobes, alter personality traits and cognitive functions, and potentially reshape society's dynamics.

Cheri Ackert-Burr, DNP, BAEd, RN, CNOR, CNS, AGTS, discusses optimizing drying strategies for medical devices, crucial in instrument processing, emphasizing efficiency gains and insights shared at the HSPA Annual Conference.

A struggling infection preventionist seeks guidance on combatting monotony and finding fulfillment in their role amidst recurring challenges.

HSPA’s 2024-2025 president, Anthony Bondon, CRCST, CHL, BSM, AAS, SME, LSSYB, spoke with Infection Control Today to discuss his goals for his tenure and more.

Explore how Exeter Hospital revamped sustainability efforts, reducing waste, improving efficiency, and saving costs in the sterile processing department, as presented at HSPA 2024.

Discover how a playful, educational approach revolutionized continuous learning for a sterile processing department from a poster presented at the HSPA Conference 2024.

Check out the highlights so far from Infection Control Today at the Healthcare Sterile Processing Association held in Las Vegas, Nevada, from April 20 to April 23, 2024.

The CMCVAMC Sterile Processing Services Department presents their roadmap for success at HSPA 2024, focusing on workflow, instrumentation, tools, tracking, and SOPs.

CSSD at Siriraj Piyamaharajkarun Hospital presents a poster at HSPA 2024, outlining efforts to streamline loaner equipment management for surgical efficiency.

This presentation by Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, at HSPA 2024, focuses on understanding and implementing ANSI/AAMI ST79 Amendment 1 to improve environmental services in sterile processing.

Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS, spoke at the HSPA Annual Conference about being survey-ready. Listen to ICT's interview to learn more!

Lisa Pawlowski, DNP, MSN-Ed, RN, CRMST, presents a poster at the HSPA 2024 Conference highlighting an evidence-based bundle that reduces SSIs by improving post-use instrument care and storage practices.

Explore the fusion of process monitoring and situation awareness in sterile processing, fostering informed decision-making for safe patient care from a presentation at HSPA24.

Danielle Zerr, MD, MPH, explains her presentations at SHEA 2024 about strategies for environmental pathogen control, the significance of patient-centered care in health care settings, and respiratory viruses in pediatric settings.

Amid escalating multidrug-resistant organism threats, hospitals face business risks and patient trust erosion, necessitating improved cleaning and infection prevention practices.

Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference evaluated adherence to laxative administration guidelines before CDI testing in Veteran Affairs (VA) hospitals and explored associated demographic and contextual factors.

Discover strategies for advocating infection prevention programs to the C-suite, ensuring resources, leadership support, and impactful outcomes.

The FDA has accepted GSK's BLA for a 5-in-1 meningococcal vaccine candidate, which promises streamlined immunization and a potential reduction in invasive meningococcal disease (IMD).